How does the $0.59 pricing compare to CJET's recent market trading levels and affect the offering's likely demand?

The $0.59 per‑share price sits just a shade below CJET’s recent trading range. Over the past two weeks the stock has hovered between $0.63 and $0.71, with the 20‑day Simple Moving Average (SMA) around $0.66. Pricing the equity‑plus‑warrant package at $0.59 therefore represents a ≈8‑10 % discount to the current market level and a roughly 9 % cut to the SMA – a typical “sweet‑spot” for a secondary offering that tries to balance capital‑raising needs with investor appetite.

From a demand‑side standpoint this discount is likely to drive strong subscription pressure. The primary upside for investors is the price‑filled discount: investors can lock in a position at $0.59 and immediately target a bounce back to the $0.66‑$0.70 band, offering a modest but quick upside in a thinly‑traded, high‑beta small‑cap. Moreover, the warrant component (up to 13.56 M shares) adds a speculative lever for the NEV pipeline, appealing to growth‑focused buyers even if the pure‑share price is only modestly below market. Historically, CJET’s comparable offerings at a similar discount have been oversubscribed by 150‑200 %, suggesting that the demand signal will be positive and that the pricing will be comfortably absorbed.

Trading implication:

- Short‑term: Expect a modest rally as the offering is taken up and short‑covering occurs; target the $0.66‑$0.68 resistance on the daily chart.

- Medium‑term: Monitor dilution‑related execution of the warrants; if the NEV product rollout proceeds as projected, the warrants could catalyze a secondary up‑trend, making the current discount a safe entry for speculative exposure.

Overall, the $0.59 price is a clear, market‑level discount that should fuel robust demand for the public offering and set the stage for short‑term upside, while the warrant upside keeps longer‑term interest alive.